Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults
relmacabtagene autoleucel(CD19 CAR-T)治疗中国成人复发/难治性套细胞淋巴瘤的II期研究
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015763
Xie, Yan; Zhou, Ke-Shu; Li, Lan-Fang; Liang, Ai-Bin; Mei, Heng; Zou, De-Hui; Li, Wen-Yu; Jin, Jie; Jin, Zheng-Ming; Jing, Hong-Mei; Yang, Hai-Yan; Chen, Tong; Huang, Hui-Qiang; He, Peng-Cheng; Cao, Jun-Ning; Xia, Zhen; Gu, Yong-En; Zang, Yi-Bei; Zhou, Zi-Song; Tian, Zhao-Zhao; Zhu, Jun; Song, Yu-Qin